Overview
Multiple symmetric lipomatosis (MSL), also known as Madelung disease or Launois-Bensaude syndrome, is a rare disorder of fat metabolism characterized by the progressive, symmetric accumulation of non-encapsulated fatty masses (lipomas) around the neck, shoulders, upper arms, upper back, and trunk. These fatty deposits are typically painless but can become disfiguring and, when located in the neck region, may compress the airway, esophagus, or major blood vessels, leading to breathing difficulties, swallowing problems, or vascular complications. The condition predominantly affects middle-aged men, and there is a strong association with chronic alcohol use, though cases in non-drinkers have also been reported. MSL primarily affects the adipose tissue but can also be associated with metabolic abnormalities including dyslipidemia, glucose intolerance, insulin resistance, hyperuricemia, and liver disease. Peripheral neuropathy is a frequently observed complication, which may be related to alcohol use or to the underlying metabolic disturbance itself. Some cases have been linked to mitochondrial DNA mutations, particularly in the MT-TK gene encoding tRNA-Lys, suggesting a mitochondrial component in at least a subset of patients. There is no curative treatment for MSL. Management primarily involves surgical removal of lipomatous masses through conventional lipectomy or liposuction, though recurrence after surgery is common. Alcohol cessation is strongly recommended and may slow disease progression, although it does not typically lead to regression of existing fatty deposits. Weight management and treatment of associated metabolic conditions such as diabetes and dyslipidemia are important components of care. Monitoring for airway compromise and peripheral neuropathy is also essential in long-term follow-up.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
2 eventsUniversity of Michigan — PHASE2
Assistance Publique - Hôpitaux de Paris — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Multiple symmetric lipomatosis.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Multiple symmetric lipomatosis.
Community
No community posts yet. Be the first to share your experience with Multiple symmetric lipomatosis.
Start the conversation →Latest news about Multiple symmetric lipomatosis
Disease timeline:
New recruiting trial: Prospective Study on the Consequences of Weight Loss After Bariatric Surgery on Obese Patients' Spine.
A new clinical trial is recruiting patients for Multiple symmetric lipomatosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Multiple symmetric lipomatosis
What is Multiple symmetric lipomatosis?
Multiple symmetric lipomatosis (MSL), also known as Madelung disease or Launois-Bensaude syndrome, is a rare disorder of fat metabolism characterized by the progressive, symmetric accumulation of non-encapsulated fatty masses (lipomas) around the neck, shoulders, upper arms, upper back, and trunk. These fatty deposits are typically painless but can become disfiguring and, when located in the neck region, may compress the airway, esophagus, or major blood vessels, leading to breathing difficulties, swallowing problems, or vascular complications. The condition predominantly affects middle-aged m
At what age does Multiple symmetric lipomatosis typically begin?
Typical onset of Multiple symmetric lipomatosis is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Multiple symmetric lipomatosis?
Yes — 1 recruiting clinical trial is currently listed for Multiple symmetric lipomatosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Multiple symmetric lipomatosis?
13 specialists and care centers treating Multiple symmetric lipomatosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.